window.pageData = {"stock":{"_id":3000000011674,"name":"长城医药科技六个月持有期混合型证券投资基金","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","exchange":"jj","stockCode":"011674","tickerId":11674,"shortName":"长城医药科技六个月混合C","inceptionDate":"2021-06-08T16:00:00.000Z","fundCollectionId":4000050150000,"currency":"CNY","followedNum":3,"status":"normal","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":105404695.59,"setUpShares":105404695.59,"masterFundFlag":null,"activeFundFlag":null,"classificationFlag":null,"closedEnd":null,"etfFundFlag":null,"feederFundFlag":null,"indexFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"pinyin":"ccyykjlgycyqhhxzqtzjj","fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50150000","tickerId":50150000,"name":"长城基金管理有限公司"},"managers":[{"name":"谭小兵","stockType":"fund_manager","stockCode":"db20424371","exchange":"fm","tickerId":202402163390}],"hotMetrics":{"fss":{"stockId":3000000011674,"type":"fss","f_s_s_d":"2024-06-29T16:00:00.000Z","f_ins_h_s_r":0,"f_ind_h_s_r":1,"f_h_a":7015,"f_h_s_a":7222,"f_ind_h_s_r_c_1y":0,"f_ind_h_s_r_c_hy":0,"f_ins_h_s_r_c_1y":0,"f_ins_h_s_r_c_hy":0,"last_data_date":"2025-06-29T16:00:00.000Z"},"fpr":{"stockId":3000000011674,"type":"fpr","f_p_r_fys_ssc":9010,"f_p_r_fys_ssrp":0.38872238872238873,"f_p_r_m1_ssc":9164,"f_p_r_m1_ssrp":0.22820037105751392,"f_p_r_m3_ssc":9022,"f_p_r_m3_ssrp":0.7375013856556922,"f_p_r_m6_ssc":8759,"f_p_r_m6_ssrp":0.9140214660881479,"f_p_r_y1_ssc":8328,"f_p_r_y1_ssrp":0.5279212201272967,"f_p_r_y2_ssc":7707,"f_p_r_y2_ssrp":0.41253568647806904,"f_p_r_y3_ssc":6876,"f_p_r_y3_ssrp":0.6132363636363637,"f_cagr_p_r_fs_ssc":9068,"f_cagr_p_r_fs_ssrp":0.9259953678173597},"fp":{"stockId":3000000011674,"type":"fp","f_p_r_fys":0.06777613743121624,"f_p_r_m1":0.07093821510297449,"f_p_r_m3":-0.02332433095998132,"f_p_r_m6":-0.042714474792445056,"f_p_r_y1":0.26687898089171824,"f_cagr_p_r_fs":-0.04600718671943527,"f_p_r_d1":0.0025256777235225236,"f_p_r_y2":0.43895822029300047,"f_p_r_y3":0.09753069388881097,"last_data_date":"2026-04-16T16:00:00.000Z"},"ff":{"stockId":3000000011674,"type":"ff","f_m_f":2689468,"f_m_f_r":0.012,"f_c_f":448244,"f_c_f_r":0.002,"f_m_a_c_f":3137712,"f_m_a_c_f_r":0.014,"f_m_c_f_d":"2024-08-08T16:00:00.000Z","f_c_fr":0.002,"f_fr_d":"2025-08-07T16:00:00.000Z","f_m_fr":0.012,"f_mac_fr":0.014},"f_nlacan":{"stockId":3000000011674,"type":"f_nlacan","f_nv_d":"2026-04-16T16:00:00.000Z","f_nv":0.7956,"f_nv_cr":-0.015468382625912769},"f_as":{"stockId":3000000011674,"type":"f_as","f_tas":44875722.6035,"f_tas_d":"2025-12-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj"}],"shareholdings":[{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":600276,"holdings":597320,"marketCap":35582352,"netValueRatio":0.0902,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.16743535988819047,"stock":{"stockCode":"600276","exchange":"sh","stockType":"company","tickerId":600276,"name":"恒瑞医药"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":1000000000001801,"holdings":461298,"marketCap":31769835,"netValueRatio":0.0806,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.2090248962655593,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":1000000000001530,"holdings":1353000,"marketCap":29549330,"netValueRatio":0.0749,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.19399999999999962,"stock":{"stockCode":"01530","exchange":"hk","stockType":"company","tickerId":1530,"name":"三生制药"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":1000000000006990,"holdings":76800,"marketCap":27205853,"netValueRatio":0.069,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.2369649805447468,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":1000000000009606,"holdings":99800,"marketCap":26880152,"netValueRatio":0.0682,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.17986798679867977,"stock":{"exchange":"hk","stockType":"company","stockCode":"09606","tickerId":9606,"name":"映恩生物-B"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":688382,"holdings":880791,"marketCap":23992746,"netValueRatio":0.0609,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.12439729990356829,"stock":{"name":"益方生物","exchange":"sh","stockType":"company","stockCode":"688382","tickerId":688382}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":2653,"holdings":367200,"marketCap":18844704,"netValueRatio":0.0478,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.040029928918817625,"stock":{"stockCode":"002653","exchange":"sz","stockType":"company","tickerId":2653,"name":"海思科"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":1000000000009926,"holdings":178059,"marketCap":18173388,"netValueRatio":0.0461,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.1997167138810193,"stock":{"stockType":"company","exchange":"hk","stockCode":"09926","tickerId":9926,"name":"康方生物"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":688513,"holdings":288243,"marketCap":17741356,"netValueRatio":0.045,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":0.11221539573545303,"stock":{"stockCode":"688513","tickerId":688513,"exchange":"sh","stockType":"company","name":"苑东生物"}},{"date":"2025-12-30T16:00:00.000Z","fundId":3000000011673,"stockId":2294,"holdings":349800,"marketCap":17332590,"netValueRatio":0.044,"declarationDate":"2026-01-21T16:00:00.000Z","quarterlyChange":-0.17895608947804464,"stock":{"stockCode":"002294","exchange":"sz","stockType":"company","tickerId":2294,"name":"信立泰"}}]},"list":[{"_id":"69aeceaf7fea5b3eb04efec4","date":"2025-12-30T16:00:00.000Z","declarationDate":"2026-01-21T16:00:00.000Z","stockId":3000000011673,"sao":"四季度市场震荡上行，宏观上海内外相对平稳，上证指数基本在近200个点之内震荡。方向上，军工、石化、有色、钢铁、轻工、消费者服务、通信等指数涨幅均在11%以上，基本就是商业航天、有色、电新、AI相关及预期反转的服务消费为主力；而医药、房地产、传媒、食品饮料等涨幅落后，指数跌幅在4%以上，特别是医药，跌了近10%。操作上，本基金综合考虑景气度与博弈情况，基本还是聚焦在政策受益及海外BD不断超预期的创新药上。","lastUpdated":"2026-03-09T13:44:15.339Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2025年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1460079","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efec3","date":"2025-09-29T16:00:00.000Z","declarationDate":"2025-10-27T16:00:00.000Z","stockId":3000000011673,"sao":"三季度市场一路上扬，在中美贸易关税谈判延缓到四季度后，市场大幅反弹，并在季度末上证打到了近3900点。方向上，计算机、电子、有色、新能源、通信、化工、机械等指数涨幅均在30%以上，基本就是AI相关、有色、电新、机器人四大领域的主力；而银行、石化、交运、食品饮料、电力等涨幅落后，就是过去三年涨幅较大的红利与宏观经济相关的消费并不太好。创新药因为在今年的3月到7月期间表现出色，8-9月份出现了高位震荡调整。操作上，本基金综合考虑景气度与博弈情况，基本还是聚焦在政策受益及海外BD不断超预期的创新药上。","lastUpdated":"2026-03-09T13:44:15.336Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2025年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1380718","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efec2","date":"2025-06-29T16:00:00.000Z","stockId":3000000011673,"sao":"25年上半年除了在4月初受川普超预期的关税大跌之外，市场其他时间均是稳步上移，并在季度末创了今年以来的新高。方向上，有色、金融科技、创新药、新消费、银行、算力、军工、反内卷的周期等表现均不错，指数涨幅都是15%以上；而纯粹内需及宏观经济相关的食品饮料、地产、煤炭、石化等表现不好，指数涨幅在2%以内。但整体来说，上半年的赚钱效应还是非常不错。本基金在宏观环境变化所导致的市场风格转变下，聚焦于业绩改善最明显的创新药领域。","declarationDate":"2025-07-11T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.334Z","mo":"展望2025年下半年，我们认为市场还是具备机会，一方面美联储处于降息周期、全球流动性环境有望改善；另一方面国内经济依然处于弱复苏轨道中，财政与货币政策较2024年有更大的空间。虽然中间可能或有中美贸易摩擦等加剧波动，但国内政策方面可能会有对冲。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在创新药。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2025年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1346407","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efec1","date":"2025-03-30T16:00:00.000Z","stockId":3000000011673,"sao":"一季度在政策的积极推动下，市场风险偏好较高，部分板块如科技、机器人、创新药等新兴产业在政策支持和产业发展双重推动下表现较为突出；而消费板块中的可选消费如汽车、家电等在以旧换新政策刺激下也有一定的复苏迹象；而传统蓝筹和周期红利则表现较弱。整体市场在一季度呈现震荡格局，除了微盘与小盘指数外，其他各大指数一直呈现震荡格局。具体表现上，有色、汽车、机械、计算机、传媒等涨幅比较大，在5%以上；而煤炭、商贸零售、非银、石化、房地产、交运、建筑等因基本面并没有明显改善，表现不佳，跌幅在5%以上。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在政策受益的创新药、高景气度的减肥药产业链以及估值性价比合理的部分股票等。","declarationDate":"2025-04-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.331Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2025年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1269134","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efec0","date":"2024-12-30T16:00:00.000Z","stockId":3000000011673,"sao":"24年市场波动加剧，呈现先抑后扬状态，结构分化非常明显，方向上基本就是围绕着红利与主题。这一方面是国内宏观经济从强预期回到弱现实，24年经济大概率处于弱复苏阶段，但刺激政策不断；另一方面美国经济衰退也表现出强韧性，加息缩表预期来回反复。在这些因素之下，全年上证指数、沪深300、创业板指数涨幅在12-15%之间，风格上，大金融、家电、通信、电子、计算机、汽车等均不错，整体来说就是红利和科技两头均有较强的超额收益，而消费、医药处于垫底状态。本基金在宏观环境变化所导致的市场风格转变下，聚焦于创新药及院外刚需等领域。","declarationDate":"2025-01-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.328Z","mo":"展望2025年，我们认为市场还是具备机会，一方面美联储处于降息周期、全球流动性环境有望改善；另一方面国内经济依然处于弱复苏轨道中，财政与货币政策较2024年有更大的空间。虽然年中可能或有中美贸易摩擦等加剧波动，但国内政策方面可能会有对冲。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在创新药、低基数的院内线、以及偏消费属性的领域（如减肥药、院外刚需）等。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2024年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1256910","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efebf","date":"2024-09-29T16:00:00.000Z","stockId":3000000011673,"sao":"三季度市场先抑后扬，7-9月中旬一直缩量阴跌，除了少数的红利股，基本没有能跑出来的细分成长股。这一方面是国内宏观经济从强预期回到弱现实，市场对未来经济趋势普遍偏悲观；另一方面美国经济衰退也表现出强韧性，加息缩表预期来回反复。直到9月下旬，出台了一系列以货币、资本市场为主的政策，改善了资本市场和宏观流动性，市场出现了大幅反弹。具体表现上，非银、地产、传媒、计算机等涨幅比较大，在30%以上；而石化、电力、煤炭、有色等前三季度表现比较好的周期红利表现比较差，涨幅在12%以内。医药板块因前期跌幅较大，指数涨幅在21%左右，相对靠前面。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在政策受益的创新药、高景气度的减肥药产业链以及集采出清、估值性价比合理的部分股票等。","declarationDate":"2024-10-23T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.325Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2024年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1171277","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efebe","date":"2024-06-29T16:00:00.000Z","stockId":3000000011673,"sao":"24年上半年市场波动加剧，呈现先抑后扬状态，结构分化非常明显，方向上基本就是围绕着红利与主题。这一方面是国内宏观经济从强预期回到弱现实，24年经济大概率处于弱复苏阶段；另一方面美国经济衰退也表现出强韧性，加息缩表预期来回反复。在这些因素之下，半年度上证指数和沪深300指数基本持平，创业板指数下跌11%。风格上，红利、出海及资源类表现较好。本基金在宏观环境变化所导致的市场风格转变下，聚焦于创新药、中成药及院外刚需等领域。","declarationDate":"2024-07-17T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.323Z","mo":"展望下半年，我们判断成长股的机会会好于上半年，一方面经济复苏较弱已被充分预期，且不排除有一些经济刺激政策出台；二是进入9月份后，美国存在降息的概率，流动性方面会有所改善；三是A股自身估值处于偏低水平。结构上相对肯定更偏均衡一些。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在创新药、低基数的院内线、以及偏消费属性的领域（如减肥药、院外刚需）等。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2024年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1154256","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efebd","date":"2024-03-30T16:00:00.000Z","stockId":3000000011673,"sao":"一季度市场先抑后扬，经历1月至2月初的深度下跌后，于春节前开始连续反弹至今，走出深V走势。市场反弹过程中各行业轮动普涨，但整体来看超跌反弹态势显著：前期大幅调整的中小盘、科技成长（TMT、高端制造）等方向显著反弹并领涨。但年初以来具体表现上，由于美国经济韧性，降息预期一推再推，叠加中国3月份PMI恢复超预期，有色、石化、煤炭等资源类及高景气度的出口表现较好，指数涨幅均在10%以上；而一季度经营业绩预期承压的医药、计算机、电子、军工等成长方向明显落后，指数跌幅还在10%以上。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在政策受益的中药消费、创新药以及集采出清、估值性价比合理的部分股票等。","declarationDate":"2024-04-19T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.320Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2024年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1075227","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efebc","date":"2023-12-30T16:00:00.000Z","stockId":3000000011673,"sao":"23年全年市场波动加剧，呈现先扬后抑、震荡下行状态。一方面疫情之后，宏观经济复苏明显低于市场预期，特别是6月份，经济显示出后劲不足的迹象；另一方面美国经济明显好于预期，十年美债收益率不断走高，人民币汇率压力较大，大幅贬值，外资直接净流出。在这些利空因素之下，全年上证指数下跌3.7%，沪深300指数下跌11.4%，创业板指数下跌19.4%。风格上，红利与微盘表现较好。本基金在宏观环境变化所导致的市场风格转变下，聚焦于CXO、创新药、中成药等领域。","declarationDate":"2024-01-18T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.317Z","mo":"展望24年，我们整体判断应该能好于23年，一是房地产对经济的拖累影响已经打到底部区域、哪怕再往下空间也非常有限，所以市场对经济复苏较弱已有充分预期，且不排除有一些经济刺激政策出台，二是A股自身估值处于偏低水平。结构上相对肯定更偏均衡一些。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在高景气领域的CXO、中药消费以及集采出清、估值性价比合理的部分股票等。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2023年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1056929","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efebb","date":"2023-09-29T16:00:00.000Z","stockId":3000000011673,"sao":"三季度市场下跌比较多，结构分化非常明显，方向上基本就是围绕着政策。这一方面是国内宏观经济从强预期回到弱现实，23年经济大概率处于弱复苏阶段；另一方面美国经济衰退也表现出强韧性，加息缩表预期来回反复。具体表现上，与稳增长相关的方向表现强劲，如煤炭、非银、银行、石化、房地产等，基本指数涨幅都在4%以上，这与7月份的政治经济局会议上的政策超预期有关。而之前表现较强的科技与新能源表现落后，医药板块表现先抑后扬，整体表现居中偏上。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在政策受益的中药消费、创新药以及集采出清、估值性价比合理的部分股票等。","declarationDate":"2023-10-24T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.315Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2023年第三季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=992438","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeba","date":"2023-06-29T16:00:00.000Z","stockId":3000000011673,"sao":"23年上半年市场波动加剧，呈现先扬后抑、震荡下行状态。一方面疫情之后，宏观经济复苏明显低于市场预期，特别是6月份，经济显示出后劲不足的迹象；另一方面美国经济明显好于预期，十年美债收益率不断走高，人民币汇率压力较大，二季度大幅贬值，外资直接净流出。在这些利空因素之下，二季度上证指数下跌2.16%，沪深300指数下跌5.15%，创业板指数下跌7.69%。风格上，科技和高端制造板块表现较好。本基金在宏观环境变化所导致的市场风格转变下，聚焦于CXO、创新药、中成药等领域。","declarationDate":"2023-07-19T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.308Z","mo":"展望下半年，我们整体判断机会会好于上半年，一是经济复苏较弱已被充分预期，且不排除有一些经济刺激政策出台，二是国际关系有缓和趋势，三是A股自身估值处于偏低水平。结构上相对肯定更偏均衡一些。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在高景气领域的CXO、中药消费以及集采出清、估值性价比合理的部分股票等。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2023年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=966603","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb9","date":"2023-03-30T16:00:00.000Z","stockId":3000000011673,"sao":"一季度市场反弹较多，结构分化非常明显，方向上基本就是围绕着政策与主题。这一方面是国内宏观经济从强预期回到弱现实，23年经济大概率处于弱复苏阶段；另一方面美国经济衰退也表现出强韧性，加息缩表预期来回反复。具体表现上，TMT板块与国企改革反弹最迅猛，如计算机、传媒、通信、电子、建筑等，基本指数涨幅都在10%以上，特别是受益于AI的细分领域，指数涨幅均在30%以上。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在政策受益的中药消费、创新药以及集采出清、估值性价比合理的部分股票等。","declarationDate":"2023-04-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.306Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2023年第一季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=885432","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb8","date":"2022-12-30T16:00:00.000Z","stockId":3000000011673,"sao":"22年是非常艰难的一年，国外一方面高通胀打破了过去宽货币的常态，美联储一直给予加息的预期，十年美债收益率也是不断走高；另一方面贸易摩擦不断，逆全球化趋势明显，俄乌战争又加剧了国际之间的矛盾。而国内这边，新冠疫情不断，从2季度的上海封城到4季度的全面阳，经济活动受到严重的阻碍，企业的报表端受到了比较大冲击，经济增长也大幅低于年初的预期。在这些利空因素之下，全球资本市场都遭受了巨大的打击，跌幅都比较大，属于典型的熊市。本基金在宏观环境变化所导致的市场风格转变下，聚焦于CXO、医疗服务、中成药等领域。","declarationDate":"2023-01-19T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.302Z","mo":"展望2023年，过去一年的压制因素正在逐步解决。海外高通胀虽然还在延续，但从先行指标来看，美国经济已经看到衰退的迹象，预计加息的节奏会变缓，这对十年美债收益率的冲击要远少于去年；另一方面，俄乌战争虽然还没结束，但欧美处于发展经济的需要，在摩擦上不会进一步加剧。国内这边情况更好，疫情对经济活动的影响基本得到消减，从23年一季度的先行指标看，宏观经济得以修复的概率极大。在这几重因素催化下，23年不管是经济还是资本市场，都值得期待。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在高景气领域的CXO、中药消费、疫情防控概念以及集采出清、估值性价比合理的部分股票等。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2022年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=872818","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb7","date":"2022-09-29T16:00:00.000Z","stockId":3000000011673,"sao":"三季度市场整体而言不太好，结构分化也比较明显。一方面国内疫情反复、经济增长动能不足，稳增长政策也是雷声大雨点小，另一方面海外通胀持续超预期，美联储加息缩表一再升温，美国十年期国债收益率不断攀升，而俄乌战争进一步加剧了全球通胀压力以及国内的经济增长压力，在多重因素影响之下，股市也是困难重重，相对而言受益于能源通胀的煤炭、石化、交运等板块表现比较好，而消费、医药、汽车等板块则出于对未来经济增长前景的担忧而跌幅较大。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在高景气领域的CXO、中药消费以及集采出清、估值性价比合理的部分股票等。","declarationDate":"2022-10-25T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.299Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2022年第三季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=809372","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb6","date":"2022-06-29T16:00:00.000Z","stockId":3000000011673,"sao":"2022年上半年的医药延续了21年惨淡行情，继续消化估值，究其本质我们认为有两方面的原因，一方面集中在新能源、顺周期等板块对医药的持续抽水效应，另一方面主要是医药自身政策的混沌加剧带来的影响，“内忧外患”造成了医药指数全年震荡估值消化。其中政策是市场最关注的地方，简单来说就是集中采购从过去几年的药品和高值耗材领域逐渐扩散到了IVD领域、设备领域以及医保外领域（如生长激素等），这进一步放大了投资者对医药未来的担忧。本基金本着围绕政策免疫思路，综合考虑景气度与博弈情况，布局的方向有所增加，基本聚焦在高景气领域的CX0、科研服务、消费医疗以及估值性价比合理的部分次新股等。","declarationDate":"2022-07-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.297Z","mo":"面对医药短期弱势，我们把眼光拉长来看，医药行业长期增长的本质是什么？是医药刚需的长期拉动，是健康消费升级的长期拉动，并且当下的需求满足度和渗透率极低，这是医药最为长期的大逻辑，但是因为市场对于支付端变革政策的担忧，似乎忽略了这个本质，支付端政策不会是一个刚性行业的长逻辑限制，最多算中短期干扰项。中长期看，我们是乐观的。GDP处于增速下行阶段，经济结构持续调整，而我国医药产业又处于成长早期阶段，存在逆向剪刀差，比较优势是强化的。七普人口数据出炉，我国人口结构正在发生巨变，未来因为巨大人口红利带动的很多行业发展逻辑都将面临巨变，市场会越来越关注并去寻找增量属性比较优势行业，逻辑周期够长且确定性够强的行业排在最前列的非医药莫属。  在再经过22年上半年的继续暴跌后，医药调整到这个位置，从中长期来看已经进入到了配置区间。本基金本着自下而上的思路去选择个股，总结下来有三点：（1）选择具备“基本面理性估值下的估值折价”，即跌到了非理性估值区间的；（2）弱化市值大小的考量；（3）精选政策鼓励，至少政策免疫。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2022年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=787591","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb5","date":"2022-03-30T16:00:00.000Z","stockId":3000000011673,"sao":"一季度市场整体而言表现不佳，结构分化也比较明显。一方面国内经济增长动能有所减弱，稳增长的预期增强，另一方面海外通胀加剧，美联储加息缩表的预期一再升温，美国十年期国债收益率不断攀升，而俄乌战争以及吉林上海等地疫情的爆发进一步加剧了全球通胀压力以及国内的经济增长压力，在多重因素影响之下，股市也是困难重重，相对而言受益于能源通胀和稳增长预期的煤炭、地产，建筑等板块表现比较好，而消费、医药、新能源、半导体、等板块则出于对未来增长前景的担忧而跌幅较大。操作上，本基金综合考虑景气度与博弈情况，基本聚焦在高景气领域的CDMO、中药消费以及估值性价比合理的部分股票等。","declarationDate":"2022-04-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.294Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2022年第一季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=730105","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb4","date":"2021-12-30T16:00:00.000Z","stockId":3000000011673,"sao":"2021年的医药表现较为惨淡，迎来估值消化的一年，究其本质我们认为有两方面的原因，一方面集中在新能源、顺周期等板块对医药的持续抽水效应，另一方面主要是医药自身政策的混沌加剧带来的影响，“内忧外患”造成了医药指数全年震荡估值消化。其中政策是市场最关注的地方，简单来说就是集中采购从过去几年的药品和高值耗材领域逐渐扩散到了IVD领域、设备领域以及医保外领域（如生长激素等），这进一步放大了投资者对医药未来的担忧。本基金本着围绕政策免疫思路，综合考虑景气度与博弈情况，布局的方向有所增加，基本聚焦在高景气领域的CDMO、科研服务、中药消费以及估值性价比合理的部分次新股等。","declarationDate":"2022-01-23T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.292Z","mo":"面对医药短期弱势，我们把眼光拉长来看，医药行业长期增长的本质是什么？是医药刚需的长期拉动，是健康消费升级的长期拉动，并且当下的需求满足度和渗透率极低，这是医药最为长期的大逻辑，但是因为市场对于支付端变革政策的担忧，似乎忽略了这个本质，支付端政策不会是一个刚性行业的长逻辑限制，最多算中短期干扰项。中长期看，我们是乐观的。GDP处于增速下行阶段，经济结构持续调整，而我国医药产业又处于成长早期阶段，存在逆向剪刀差，比较优势是强化的。七普人口数据出炉，我国人口结构正在发生巨变，未来因为巨大人口红利带动的很多行业发展逻辑都将面临巨变，市场会越来越关注并去寻找增量属性比较优势行业，逻辑周期够长且确定性够强的行业排在最前列的非医药莫属。  在再经过22年一月份的继续暴跌后，医药调整到这个位置，从中长期来看已经进入到了配置区间。本基金本着自下而上的思路去选择个股，总结下来有三点：（1）选择具备“基本面理性估值下的估值折价”，即跌到了非理性估值区间的；（2）弱化市值大小的考量；（3）精选政策鼓励，至少政策免疫。","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2021年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=716594","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aeceaf7fea5b3eb04efeb3","date":"2021-09-29T16:00:00.000Z","stockId":3000000011673,"sao":"新冠疫苗接种推进较快、叠加新冠治疗药物的研发数据也较为振奋人心，市场对宏观经济的恢复预期较满，但三季度在能源短缺刺激下，石油、煤炭等能源价格飙升，能源危机让全球对通胀的担忧上升，以成长股为代表的各种指数在8-9月份震荡往下。展望四季度，我们认为，大面积停电限产或使经济进一步减速，4季度经济形势不容乐观，好在从货币政策和居民资产配置的角度看，流动性环境可能好于预期，再加上A股估值并不过分，因此市场出现系统性风险的概率不大，我们判断四季度大部分时间市场可能以持续震荡为主要格局，年底和明年一季度可能会有行情。操作上，本基金根据市场情况择机上仓位，依然会聚焦于高景气领域的CXO、医疗服务、疫苗等领域。","declarationDate":"2021-10-26T16:00:00.000Z","lastUpdated":"2026-03-09T13:44:15.289Z","fund":{"_id":3000000011673,"__csrcFundId":9214,"stockCode":"011673","shortName":"长城医药科技六个月混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":11673,"masterFundFlag":1,"lastUpdated":"2025-01-01T23:59:28.885Z","status":"normal","name":"长城医药科技六个月持有期混合型证券投资基金","exchange":"jj","followedNum":5,"fundCollectionId":4000050150000,"inceptionDate":"2021-06-08T16:00:00.000Z","currency":"CNY","masterFundShortName":"长城医药科技六个月混合","setUpDate":"2021-06-08T16:00:00.000Z","setUpAssetScale":1021465801.13,"setUpShares":1021465801.13,"pinyin":"ccyykjlgycyqhhxzqtzjj","managers":[{"stockCode":"db20424371","stockType":"fund_manager","exchange":"fm","tickerId":202402163390,"name":"谭小兵"}]},"announcement":{"linkText":"长城医药科技六个月持有期混合型证券投资基金2021年第三季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=658292","linkType":"PDF","source":"csrc_pdf"}}]}